PodParley PodParley

CONTROVERSIAL DRUG KEY TO FIGHTING RSV?

Despite an aggressive media hit job on the 40 year-old Nobel Prize-winning drug, a recent study, coupled with the rising rates of RSV in children, has thrust ivermectin into the spotlight once again. Is the controversial drug the key to fighting RSV?

An episode of the The Highwire with Del Bigtree podcast, hosted by The Highwire with Del Bigtree, titled "CONTROVERSIAL DRUG KEY TO FIGHTING RSV?" was published on November 19, 2022 and runs 14 minutes.

November 19, 2022 ·14m · The Highwire with Del Bigtree

0:00 / 0:00

Despite an aggressive media hit job on the 40 year-old Nobel Prize-winning drug, a recent study, coupled with the rising rates of RSV in children, has thrust ivermectin into the spotlight once again. Is the controversial drug the key to fighting RSV?Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

Despite an aggressive media hit job on the 40 year-old Nobel Prize-winning drug, a recent study, coupled with the rising rates of RSV in children, has thrust ivermectin into the spotlight once again. Is the controversial drug the key to fighting RSV?

Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
URL copied to clipboard!